Quilaban and Autobio Diagnostics join forces to strengthen innovation in clinical diagnostics

The partnership between Quilaban and Autobio Diagnostics marks an important step in laboratory diagnostics, bringing high-precision and fully automated CLIA technologies to Portugal.

Quilaban has established a partnership with Autobio Diagnostics, an internationally recognised company known for developing advanced solutions in immunological, microbiological and molecular diagnostics. This collaboration reinforces Quilaban’s commitment to offering cutting-edge technology and delivering faster, more reliable and more efficient laboratory results.

With more than 20 years of experience, Autobio Diagnostics is a global reference in the sector, standing out for its continuous innovation, automation and scientific rigor in analytical platforms. Its expertise in the CLIA (Chemiluminescent Immunoassay) segment enables sensitive and accurate detection of clinical markers, supporting diagnostics across multiple areas of laboratory medicine.

Through this partnership, Quilaban will provide laboratories and healthcare professionals with integrated solutions that improve result quality and operational efficiency.

Together, Quilaban and Autobio Diagnostics promote scientific innovation and support clinical diagnostics in Portugal, always with a commitment to quality, trust and continuous progress.